Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $1.5 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”):
- NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $1.5 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”):
The Notes will be guaranteed on a senior unsecured basis by Royalty Pharma Holdings Ltd. - The offering is expected to close on June 10, 2024, subject to the satisfaction of customary closing conditions.
- Royalty Pharma intends to use the net proceeds from the Notes for general corporate purposes.
- The Notes are being offered pursuant to an effective shelf registration statement that the Company filed with the Securities and Exchange Commission (the “SEC”).